We don’t have a sales consultant in front of us in that situation. There is nobody to demonstrate and reassure …
Wholesale shifting of pharmaceutical production to low-cost countries such as India and China is creating environmental impacts “on a scale …
Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and …
Belgian fine chemicals company Ajinomoto OmniChem has forged a joint venture with Granules India to produce active pharmaceutical ingredients and …

Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …
Novartis says it is “disappointed” with health watchdog NICE’s decision not to recommend Lucentis for the treatment of eye problems …
Amgen’s bone cancer drug Xgeva (denosumab) has been approved in Europe to prevent serious bone problems in cancer patients. Already …

GlaxoSmithKline is cutting around 130 jobs at a facility in Waterford, Ireland, over the next three years as part of …
Our round-up of news in the pharmaceutical manufacturing sector includes facility updates from NanoSonic, Tianyin Pharma, Orchid and Boehringer Ingelheim, …

How many iPads has Boehringer Ingelheim ordered for its sales force in Turkey? Do Novartis’ investors really want their annual …
German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …

Specialist health agency Reynolds-MacKenzie has become the latest recruit to the Open Health stable, bolstering the new communications group’s PR …
You might not have noticed, but the government has performed a major U-turn. No, I don’t mean the NHS reform …
Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …

UK doctors have been told not to accept patients as Facebook friends in order to maintain professional boundaries. The BMA’s …

Bristol-Myers Squibb’s skin cancer vaccine Yervoy has been approved in Europe after showing survival benefits in one of the most …
France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
Spain’s pharma industry has hit out against the drastic budget cuts the government introduced last year, saying they’ve led to …
The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …
French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …